Historical record - last NADAC effective date: 7/1/2024

Product Information

TIROSINT-SOL 62.5 MCG/ML SOLN is a brand product labeled by IBSA Pharma Inc., priced at $4.5966 per ML under NDC 71858011705. Its NADAC has been published 25 times since Apr 17, 2024.

FDA first approved this application on Dec 15, 2016.

The High Outlier badge above means this manufacturer's average price in the Levothyroxine Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIROSINT-SOL 62.5 MCG/ML SOLN

Levothyroxine Sodium
$4.5966per ML
High Outlier

Strength

62.5 ug/mL

Manufacturer

IBSA Pharma Inc.

NDC

71858011705

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

7/1/2024

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA206977

FDA Approved

12/15/2016

On Market Since

7/1/2021

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for TIROSINT-SOL 62.5 MCG/ML SOLN has been published 25 times since Apr 17, 2024, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.5966 per ML
All-time high$4.5966 (Oct 2, 2024)
All-time low$4.4329 (Apr 17, 2024)
Median price$4.5966
Average price$4.5320
Largest weekly change+3.6% (Jun 26, 2024)
Weeks tracked25
Tracking sinceApr 17, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+3.7%

Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levothyroxine Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TIROSINT-SOL 62.5 MCG/ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for TIROSINT-SOL 62.5 MCG/ML SOLN, manufactured by IBSA Pharma Inc., is $4.5966 per ML (NDC 71858011705), effective Oct 2, 2024.

How has the price of TIROSINT-SOL 62.5 MCG/ML SOLN changed over time?

Over the history we have for it, the NADAC for TIROSINT-SOL 62.5 MCG/ML SOLN has risen 3.7%. It has been tracked across 25 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for TIROSINT-SOL 62.5 MCG/ML SOLN?

Since Apr 17, 2024, the NADAC for TIROSINT-SOL 62.5 MCG/ML SOLN has ranged from a low of $4.4329 (Apr 17, 2024) to a high of $4.5966 (Oct 2, 2024), with a median of $4.5966 per ML.

Are there cheaper alternatives to TIROSINT-SOL 62.5 MCG/ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of TIROSINT-SOL 62.5 MCG/ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TIROSINT-SOL 62.5 MCG/ML SOLN?

TIROSINT-SOL 62.5 MCG/ML SOLN (NDC 71858011705) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.